GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Denis Chem Lab Ltd (BOM:537536) » Definitions » EPS (Diluted)

Denis Chem Lab (BOM:537536) EPS (Diluted) : ₹6.62 (TTM As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Denis Chem Lab EPS (Diluted)?

Denis Chem Lab's Earnings per Share (Diluted) for the three months ended in Dec. 2023 was ₹2.31. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₹6.62.

Denis Chem Lab's EPS (Basic) for the three months ended in Dec. 2023 was ₹2.31. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was ₹6.62.

Denis Chem Lab's EPS without NRI for the three months ended in Dec. 2023 was ₹2.31. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was ₹7.67.

During the past 12 months, Denis Chem Lab's average EPS without NRIGrowth Rate was 12.90% per year. During the past 3 years, the average EPS without NRIGrowth Rate was 26.20% per year. During the past 5 years, the average EPS without NRI Growth Rate was 24.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 11 years, Denis Chem Lab's highest 3-Year average EPS without NRI Growth Rate was 50.00% per year. The lowest was -34.50% per year. And the median was 25.20% per year.


Denis Chem Lab EPS (Diluted) Historical Data

The historical data trend for Denis Chem Lab's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Denis Chem Lab EPS (Diluted) Chart

Denis Chem Lab Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.58 3.03 1.63 4.51 5.66

Denis Chem Lab Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.32 0.55 1.93 1.83 2.31

Competitive Comparison of Denis Chem Lab's EPS (Diluted)

For the Drug Manufacturers - Specialty & Generic subindustry, Denis Chem Lab's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Denis Chem Lab's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Denis Chem Lab's PE Ratio distribution charts can be found below:

* The bar in red indicates where Denis Chem Lab's PE Ratio falls into.



Denis Chem Lab EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Denis Chem Lab's Diluted EPS for the fiscal year that ended in Mar. 2023 is calculated as

Diluted EPS (A: Mar. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(78.598-0)/13.877
=5.66

Denis Chem Lab's Diluted EPS for the quarter that ended in Dec. 2023 is calculated as

Diluted EPS (Q: Dec. 2023 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(32.013-0)/13.858
=2.31

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹6.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Denis Chem Lab  (BOM:537536) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Denis Chem Lab EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Denis Chem Lab's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Denis Chem Lab (BOM:537536) Business Description

Traded in Other Exchanges
N/A
Address
Satellite Road, 401 Abhishree Complex, Opposite OM Tower, Beside Bidiwala Park, Ahmedabad, GJ, IND, 380015
Denis Chem Lab Ltd is a pharmaceutical company involved in the manufacturing of pharmaceutical products. The company offers sterile intravenous injectables for human and veterinary use for different therapeutic areas. Its product portfolio includes antibiotic injections, diuretic injections, parenteral amino acid injections, plasma volume expanders, anti-pyretic Inj. irrigation solutions and dialysis solutions. The company has only one reportable segment which is Manufacturing, and Sales of Transfusion Solution in Bottles It generates its revenues through the sale of transfusion solution in bottles.

Denis Chem Lab (BOM:537536) Headlines

No Headlines